CJC + IPA + Tesamorelin

XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY

Category:Dual GHRH Analogues + GHRP | Half-life: CJC-1295 (No DAC) ~30 min, Ipamorelin ~2 h, Sermorelin ~10–20 min

Mechanism

Dual GHRH analogues with a selective GHRP enhance GH pulsatility, supporting recovery, muscle repair, and lean mass.

Dosing Protocol

500 mcg–1 mg SubQ, administered 1–2 times daily; pre-sleep preferred, with post-workout dosing as a secondary option.

Critical:

Sermorelin has an extensive safety record among GHRH analogues, making this blend suitable for recovery-focused protocols and individuals new to GH secretagogues.

LEAN-15X | Triple GH Secretagogue Blend — Fat Loss Focus | CAS: N/A

LEAN combines CJC-1295 (no DAC), Ipamorelin, and Tesamorelin into a single vial. Tesamorelin is a stabilized GHRH
analogue FDA-approved for visceral fat reduction in HIV lipodystrophy — it produces greater and more sustained GH
elevation than CJC alone. This triple-blend maximizes GH pulse amplitude with two complementary GHRH analogues plus
a GHRP.

DOSING PROTOCOL
ParameterDetails
Dose500 mcg–1 mg SubQ, 1–2× daily
TimingAM fasted + pre-sleep; avoid within 2 hours of carbohydrate meals
Cycle Length3–6 months
STACKING RECOMMENDATIONS

Pair with BPC-157 + TB-500 for connective tissue and injury repair. Add IGF-1 LR3 or PEG-MGF post-workout for satellite
cell activation. Excellent with TRT base for lean recomposition.

NOTE: Sermorelin has the longest safety record of GHRH analogues. Well-suited for older users or those new to GH secretagogues.